晚期就诊患者Norwood手术结局的演变
该研究回顾了沙特阿拉伯单中心2003至2018年145例Norwood手术患者,比较BT分流、Sano分流和一期腔肺分流三种术式。结果发现较低体重和较长转流时间预测手术死亡,较高体重、较晚年代和较短转流时间预测长期生存改善;近期Sano分流使用增加且 outcomes 改善,晚期就诊或较大年龄并非禁忌。
要点
- 较低体重和较长转流时间与Norwood手术死亡相关。
- 较高体重、较晚年代和较短转流时间与长期生存改善相关。
- 晚期就诊或较大年龄不是Norwood手术的禁忌证。
核心结论
- 近期年代和Sano分流下Norwood手术结局改善,尤其在小体重患者中。
- 晚期就诊或较大年龄不是Norwood手术的禁忌证。
- 一期行腔肺分流在选定患者中可行。
研究设计与样本
- 单中心回顾性研究,纳入2003至2018年145例Norwood手术患者。
- 按分流类型分为BT组(n=72)、Sano组(n=66)和一期腔肺分流组(n=7)。
- 研究结局为手术死亡、长期生存及多状态转换至腔肺分流、Fontan和死亡。
主要发现
- 手术死亡预测因素为较低体重(P = .026)和较长转流时间(P = .014),年龄和分流类型不是。
- 长期生存改善预测因素为较高体重(P = .0016)、较晚年代(P = .006)和较短转流时间(P = .001)。
- 多状态模型显示较低体重患者更可能接受Sano而非BT(P < .001),若选BT则死亡风险更高(P = .027)。
- 近期年代接受Sano分流的可能性增加3倍(P = .003)。
临床怎么用
- 小体重患者可优先考虑Sano分流以改善结局。
- 晚期就诊或较大年龄不应作为Norwood手术的排除标准。
- 选定患者可考虑一期行腔肺分流。
局限性
- 单中心回顾性研究,样本量有限(n=145),结果外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We present the evolution of Norwood operation outcomes and practice pattern changes over 15 years from a single institution in Saudi Arabia. We intended to identify time trends in patient selection, procedural details, and outcome predictors over time. METHODS: Patients who underwent a Norwood operation (n = 145) between 2003 and 2018 with the use of a Blalock-Taussig shunt (BT group; n = 72), right ventricle to pulmonary artery shunt (Sano group; n = 66), or a primary cavopulmonary shunt (CPS group; n = 7) were included. The study outcomes were operative mortality, long-term survival, and multistate transition to CPS, Fontan, and death. RESULTS: Median age was 29 days. Predictors of operative mortality were lower weight (P = .026), and longer bypass time (P = .014), whereas age, and type of shunt were not. Predictors of improved long-term survival were greater weight at operation (P = .0016), later era (P = .006), and shorter bypass time (P = .001). The multistate model revealed that patients with lower weight were more likely to undergo Sano versus BT (P < .001), and if BT was chosen in such patients, they were more likely to die (P = .027). The likelihood of receiving Sano shunt was 3-fold greater in the recent era (P = .003). CONCLUSIONS: Improved outcomes of the Norwood operation are evident in the recent era and with Sano shunt, especially in patients of smaller weight. Late presentation or older age is not a contraindication to Norwood operation. The incorporation of a primary CPS at stage one operation is feasible in selected patients.
引用
- Ismail MF, Elmahrouk AF, Arafat AA, et al. Evolution of the Norwood operation outcomes in patients with late presentation. J Thorac Cardiovasc Surg. 2019. PMID: 31924357. doi:10.1016/j.jtcvs.2019.07.154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。